Target Name: PDE7A
NCBI ID: G5150
Review Report on PDE7A Target / Biomarker Content of Review Report on PDE7A Target / Biomarker
PDE7A
Other Name(s): Phosphodiesterase PDE7A | PDE7A variant 3 | HCP1 | PDE7A_HUMAN | PDE7A variant 1 | PDE7A1 | PDE7 | Phosphodiesterase isozyme 7 | PDE7A2 | Phosphodiesterase 7A | phosphodiesterase isozyme 7 | TM22 | ph

Phosphodiesterase PDE7A: A Protein with Multiple Roles in Cellular Signaling

Phosphodiesterase PDE7A is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It plays a critical role in the regulation of cellular signaling pathways, and is involved in a wide range of physiological processes.

One of the key functions of PDE7A is its role in the regulation of neurotransmitter release from nerve terminals. This is important for the proper functioning of the brain and for the treatment of various neurological disorders.

In addition to its role in neurotransmitter release, PDE7A is also involved in the regulation of ion channels in the brain. This is important for the proper functioning of neural circuits and for the treatment of various neurological disorders.

PDE7A is a potential drug target for a variety of neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy. It is also a potential biomarker for these disorders, as its levels may be affected by the progression of these diseases.

In addition to its potential clinical applications, PDE7A is also of interest to researchers as a study protein. Researchers are interested in understanding its structure and function, as well as its role in various cellular signaling pathways.

Overall, PDE7A is a complex protein that plays a critical role in the regulation of cellular signaling pathways. Its functions in neurotransmitter release and ion channel regulation make it an attractive target for drug development and research into the underlying mechanisms of various neurological disorders.

Protein Name: Phosphodiesterase 7A

Functions: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes (PubMed:8389765, PubMed:9195912, PubMed:19350606). May have a role in muscle signal transduction (PubMed:9195912)

The "PDE7A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDE7A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PDE7B | PDE7B-AS1 | PDE8A | PDE8B | PDE9A | PDE9A-AS1 | PDF | PDGFA | PDGFA-DT | PDGFB | PDGFC | PDGFD | PDGFRA | PDGFRB | PDGFRL | PDHA1 | PDHA2 | PDHB | PDHX | PDIA2 | PDIA3 | PDIA3P1 | PDIA4 | PDIA5 | PDIA6 | PDIK1L | PDILT | PDK1 | PDK2 | PDK3 | PDK4 | PDLIM1 | PDLIM1P4 | PDLIM2 | PDLIM3 | PDLIM4 | PDLIM5 | PDLIM7 | PDP1 | PDP2 | PDPK1 | PDPK2P | PDPN | PDPR | PDPR2P | PDRG1 | PDS5A | PDS5B | PDS5B-DT | PDSS1 | PDSS2 | PDX1 | PDXDC1 | PDXDC2P-NPIPB14P | PDXK | PDXP | PDYN | PDYN-AS1 | PDZD11 | PDZD2 | PDZD4 | PDZD7 | PDZD8 | PDZD9 | PDZK1 | PDZK1IP1 | PDZK1P1 | PDZPH1P | PDZRN3 | PDZRN3-AS1 | PDZRN4 | PEA15 | PEAK1 | PEAK3 | PEAR1 | PeBoW complex | PEBP1 | PEBP1P2 | PEBP4 | PECAM1 | PECR | PEDS1 | PEDS1-UBE2V1 | PEF1 | PEG10 | PEG13 | PEG3 | PEG3-AS1 | PELATON | PELI1 | PELI2 | PELI3 | PELO | PELP1 | PELP1-DT | PEMT | PENK | PENK-AS1 | PEPD | Peptidyl arginine deiminase (PAD)